Oncology Nurse Advisor
@oncologynurseadv.bsky.social
OncologyNurseAdvisor.com offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
Epcoritamab reduced the risk for death by 79%. Presented at #ASH25, by Dr Falchi of @mskcancercenter.bsky.social covered by @cancertherapyadv.bsky.social.
https://bit.ly/4q4fQcb
#lymsm #follicularLymphoma
https://bit.ly/4q4fQcb
#lymsm #follicularLymphoma
December 13, 2025 at 9:11 PM
Epcoritamab reduced the risk for death by 79%. Presented at #ASH25, by Dr Falchi of @mskcancercenter.bsky.social covered by @cancertherapyadv.bsky.social.
https://bit.ly/4q4fQcb
#lymsm #follicularLymphoma
https://bit.ly/4q4fQcb
#lymsm #follicularLymphoma